Sayka Barry

925 total citations
28 papers, 674 citations indexed

About

Sayka Barry is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Oncology. According to data from OpenAlex, Sayka Barry has authored 28 papers receiving a total of 674 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Oncology. Recurrent topics in Sayka Barry's work include Pituitary Gland Disorders and Treatments (13 papers), Neuroendocrine Tumor Research Advances (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Sayka Barry is often cited by papers focused on Pituitary Gland Disorders and Treatments (13 papers), Neuroendocrine Tumor Research Advances (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Sayka Barry collaborates with scholars based in United Kingdom, United States and Portugal. Sayka Barry's co-authors include Márta Korbonits, Tatjana Crnogorac‐Jurcevic, Nicholas R. Lemoine, Pedro Marques, Claude Chelala, Eivind Carlsen, Hannah J. Whiteman, Ashley Grossman, Joan Grieve and Amy Ronaldson and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Cancer Research.

In The Last Decade

Sayka Barry

27 papers receiving 666 citations

Peers

Sayka Barry

EDM

GENET

ONCOL

Mateusz Bujko Poland

Paulina Kober Poland

Yong-Kil Hong South Korea

Naema Nayyar United States

Thomas Strömberg Sweden

Lily Ramyar Canada

Francesca Voza United States

Annett Hölsken Germany

Roger Gejman Chile

R. V. Lloyd United States

Mateusz Bujko Poland

Sayka Barry

166 ×0.5

EDM

335 ×1.1

113 ×0.7

GENET

99 ×0.6

ONCOL

133 ×0.9

Citations per year, relative to Sayka Barry Sayka Barry (= 1×) peers Mateusz Bujko

Countries citing papers authored by Sayka Barry

Since Specialization

Citations

This map shows the geographic impact of Sayka Barry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sayka Barry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sayka Barry more than expected).

Fields of papers citing papers by Sayka Barry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sayka Barry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sayka Barry. The network helps show where Sayka Barry may publish in the future.

Co-authorship network of co-authors of Sayka Barry

This figure shows the co-authorship network connecting the top 25 collaborators of Sayka Barry. A scholar is included among the top collaborators of Sayka Barry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sayka Barry. Sayka Barry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Silva, Ana Luísa, Sayka Barry, Paulo Matos, et al.. (2025). CCL2 expression predicts clinical outcomes and regulates E-cadherin and angiogenesis in pituitary tumours. Endocrine Related Cancer. 32(5). 1 indexed citations

Begalli, Federica, Stephanie G. Craig, Steven Hunter, et al.. (2022). Aberrant cyclic GMP-AMP synthase stimulator of interferon genes signalling in an AIP mutant cell line. Endocrine Abstracts. 1 indexed citations

Marques, Pedro, Sayka Barry, Eivind Carlsen, et al.. (2021). The expression of neural cell adhesion molecule and the microenvironment of pituitary neuroendocrine tumours. Journal of Neuroendocrinology. 33(12). e13052–e13052. 8 indexed citations

Barry, Sayka, Carles Gaston‐Massuet, Montserrat García-Lavandeira, et al.. (2021). RET signalling provides tumorigenic mechanism and tissue specificity for AIP-related somatotrophinomas. Oncogene. 40(45). 6354–6368. 17 indexed citations

Barry, Sayka & Márta Korbonits. (2020). Update on the Genetics of Pituitary Tumors. Endocrinology and Metabolism Clinics of North America. 49(3). 433–452. 25 indexed citations

Marques, Pedro, Sayka Barry, Eivind Carlsen, et al.. (2020). The role of the tumour microenvironment in the angiogenesis of pituitary tumours. Endocrine. 70(3). 593–606. 25 indexed citations

Barry, Sayka, Ezra Aksoy, Anna Vossenkämper, et al.. (2019). Aryl Hydrocarbon Receptor Interacting Protein Maintains Germinal Center B Cells through Suppression of BCL6 Degradation. Cell Reports. 27(5). 1461–1471.e4. 21 indexed citations

Barry, Sayka, Eivind Carlsen, Pedro Marques, et al.. (2019). Tumor microenvironment defines the invasive phenotype of AIP-mutation-positive pituitary tumors. Oncogene. 38(27). 5381–5395. 64 indexed citations

Marques, Pedro, Sayka Barry, Eivind Carlsen, et al.. (2019). MON-460 Pasireotide Treatment Inhibits Cytokine Release from Pituitary Adenoma-Associated Fibroblasts: Is This Mechanism Playing a Key Role in Its Effect?. Journal of the Endocrine Society. 3(Supplement_1). 4 indexed citations

10.

Rodd, Celia, Donato Iacovazzo, Craig E Stiles, et al.. (2016). SomaticGPR101Duplication Causing X-Linked Acrogigantism (XLAG)—Diagnosis and Management. The Journal of Clinical Endocrinology & Metabolism. 101(5). 1927–1930. 38 indexed citations

11.

Barry, Sayka, Eivind Carlsen, Emanuela Gadaleta, et al.. (2016). The role of the microenvironment in the invasive phenotype of familial pituitary tumours. Endocrine Abstracts. 2 indexed citations

12.

Dénes, Judit, Leandro Kasuki, Giampaolo Trivellin, et al.. (2015). Regulation of Aryl Hydrocarbon Receptor Interacting Protein (AIP) Protein Expression by MiR-34a in Sporadic Somatotropinomas. PLoS ONE. 10(2). e0117107–e0117107. 51 indexed citations

13.

Barry, Sayka, Emanuela Gadaleta, Claude Chelala, & Márta Korbonits. (2013). Gene expression profiling of familial and sporadic pituitary adenomas. Endocrine Abstracts. 1 indexed citations

14.

Crnogorac‐Jurcevic, Tatjana, Claude Chelala, Sayka Barry, et al.. (2013). Molecular Analysis of Precursor Lesions in Familial Pancreatic Cancer. PLoS ONE. 8(1). e54830–e54830. 31 indexed citations

15.

Barry, Sayka, Jumana Saleh, & Márta Korbonits. (2012). The role of familial pituitary adenoma gene, aryl hydrocarbon receptor-interacting protein, in the proliferative and invasive activity of a malignant pancreatic cell line. 15th International & 14th European Congress of Endocrinology. 29. 1 indexed citations

16.

Barry, Sayka, Claude Chelala, Kate E Lines, et al.. (2012). S100P is a metastasis-associated gene that facilitates transendothelial migration of pancreatic cancer cells. Clinical & Experimental Metastasis. 30(3). 251–264. 45 indexed citations

17.

Tolhurst, Robert S., Ross S. Thomas, Hetal Patel, et al.. (2010). Transient over-expression of estrogen receptor-α in breast cancer cells promotes cell survival and estrogen-independent growth. Breast Cancer Research and Treatment. 128(2). 357–368. 21 indexed citations

18.

Das, Partha, et al.. (2010). Reactivation of epigenetically silenced HER4/ERBB4 results in apoptosis of breast tumor cells. Oncogene. 29(37). 5214–5219. 36 indexed citations

19.

Whiteman, Hannah J., Mark C. Willingham, Sally E. Dowen, et al.. (2007). The Role of S100P in the Invasion of Pancreatic Cancer Cells Is Mediated through Cytoskeletal Changes and Regulation of Cathepsin D. Cancer Research. 67(18). 8633–8642. 85 indexed citations

20.

Chelala, Claude, Stephan A. Hahn, Hannah J. Whiteman, et al.. (2007). Pancreatic Expression database: a generic model for the organization, integration and mining of complex cancer datasets. BMC Genomics. 8(1). 439–439. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact